Rankings
▼
Calendar
FULC Q1 2021 Earnings — Fulcrum Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FULC
Fulcrum Therapeutics, Inc.
$436M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+538.5% YoY
Gross Profit
-$12M
-241.1% margin
Operating Income
-$17M
-355.9% margin
Net Income
-$17M
-355.0% margin
EPS (Diluted)
$-0.54
QoQ Revenue Growth
+13.3%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$156M
Total Liabilities
$29M
Stockholders' Equity
$128M
Cash & Equivalents
$101M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$750,000
+538.5%
Gross Profit
-$12M
-$14M
+15.9%
Operating Income
-$17M
-$19M
+9.3%
Net Income
-$17M
-$18M
+7.9%
← FY 2021
All Quarters
Q2 2021 →